CEPI will provide up to $5 million in additional funding to conduct a Phase 1 clinical trial of Gritstone’s Omicron vaccine candidate in South Africa.
Making vaccines available for use in 100 days will require a paradigm shift in these areas of vaccine development.
Compressing vaccine development timelines to 100 days will require a step-change in how we manufacture vaccines.
Dedicated global surveillance of high-risk pathogens can speed identification of Disease X, which will be crucial to achieving the 100 days mission.
The world can face down the next Disease X with a new vaccine in just 100 days. Here’s how…
Development of rapid-response vaccine technology will be crucial in enabling the world to achieve the 100 days mission.
Creation of vaccine libraries will help the world develop vaccines against the next Disease X in 100 days.